Streetbeat News

Price Targets

TBNK

Keefe, Bruyette & Woods analyst Kelly Motta has maintained a 'Market Perform' rating on Territorial Bancorp (NASDAQ:TBNK) but lowered the price target from $12 to $7. The report was released on November 13, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 4:05 pm

RC

Keefe, Bruyette & Woods analyst Jade Rahmani has maintained a 'Market Perform' rating on Ready Capital (NYSE:RC) but reduced the price target from $10.5 to $10. The report was released on November 13, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 4:04 pm

EVBN

Keefe, Bruyette & Woods analyst Christopher O'Connell has maintained a 'Market Perform' rating on Evans Bancorp (EVBN) and increased the price target from $25 to $26.5.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 4:01 pm

OM

Outset Medical (NASDAQ:OM) has received mixed analyst ratings in the last quarter, with an average price target of $13.17, which is significantly higher than its current price of $4.2. This target represents a 48.55% decrease from the previous target of $25.60. The ratings include 1 bullish, 2 somewhat bullish, 2 indifferent, and 1 somewhat bearish, with no bearish ratings.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 4:00 pm

TSN

Over the last quarter, Tyson Foods (NYSE:TSN) received mixed analyst ratings with 1 somewhat bullish, 1 indifferent, and 2 somewhat bearish. The average 12-month price target for TSN is $52.5, with a high of $70.00 and a low of $45.00. This target has increased by 7.14% over the past month. Analyst ratings are based on information from company activities, financial statements, and insider conversations.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 4:00 pm

GWRE

Over the past 3 months, 7 Wall Street analysts have provided ratings for Guidewire Software (NYSE:GWRE), with 1 bullish, 3 somewhat bullish, and 3 indifferent. The average 12-month price target is $97.57, with a high of $117.00 and a low of $85.00. This target has increased by 15.96% over the past month. Analysts rate stocks to predict performance and provide guidance to investors.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 4:00 pm

FLR

Fluor Corporation (NYSE:FLR) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for Fluor is $42.25, which is a 14.19% increase from the previous target of $37.00. The high target is $47.00 and the low target is $39.00. Analysts rate stocks typically once per quarter and provide insights into company performance and stock potential.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 4:00 pm

ICFI

ICF International (NASDAQ:ICFI) received 4 analyst ratings in the last quarter with 2 bullish, 1 somewhat bullish, and 1 indifferent. The average price target is $142.0, representing an upside from the current price of $135.375. This target has increased by 4.03% from the previous target of $136.50. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 4:00 pm

FNF

Over the past 3 months, 4 Wall Street analysts have published their opinions on Fidelity National Financial (NYSE:FNF), with 1 bullish, 2 somewhat bullish, and 1 indifferent rating. The average 12-month price target for FNF is $49.25, with a high of $55.00 and a low of $43.00. This target has increased by 1.55% over the past month.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 4:00 pm

IART

CL King analyst Kristen Stewart has initiated coverage on Integra Lifesciences (NASDAQ:IART) with a Buy rating and set a price target of $50.

Portfolio Pulse from Benzinga Newsdesk

November 14, 2023 | 3:59 pm